About RheoMeditech Inc.
RheoMeditech Inc., founded in 2003, specializes in blood test in-vitro diagnostic device and has developed by publishing a number of technical and clinical papers to the international Association. RheoMeditech Inc. is a leading manufacturer of wide range of in vitro diagnostic analyzers, test kits, and consumables.
We seek to improve human health and healthcare. Based on our advanced technology, we commercialized RheoScan, the world's first clinical blood circulation system in 2007 and is using it as a diagnostic technology for diabetes microvascular diseases. Anysis, the Platelet Complex Function Analyzer, was commercialized and we were able to perform five tests such as the ADP, Epi, and Aspirin test. RheoESR, which can measure ESR(Erythrocyte Sedimentation rate) in 20 seconds, is almost ready to be out in the medical field. 60 test tubes can be inserted.
RheoMeditech offers early screening and diagnostics that provide health care professionals to make better decisions. With greater trust, we can help people achieve better health through our early diagnosis systems with innovative technology. The best treatment starts with early detection.
We provide what patients need now.
RheoMeditech ISO 13485
Free Sales Certificate
CE DoC Rheoscan
CE DoC Anysis
IVD Manufacturing License
MEDICA 2020 . 11 . 16~19 : Dusseldorf, Germany
AACC 2020 . 12 . 13~ 17 : Chicago, United States of America
KIMES 2021 . 03.18-21 : Seoul, Korea
MEDICA 2019 : Dusseldorf, Germany
KIMES 2021 : Seoul, Korea